albuterol has been researched along with Alloxan Diabetes in 13 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Probucol is an antihyperlipidemic drug with potent antioxidant properties." | 1.46 | Probucol prevents the attenuation of β ( Higashi, K; Ishii, K; Mori, A; Nakahara, T; Sakamoto, K; Wakao, S, 2017) |
| "Insulin resistant type 2 diabetes mellitus in the obese elderly has become a worldwide epidemic." | 1.38 | Chronic β2 adrenergic agonist, but not exercise, improves glucose handling in older type 2 diabetic mice. ( Elayan, H; Gharaibeh, M; Milic, M; Sun, P; Ziegler, MG, 2012) |
| "3." | 1.29 | The effects of glyburide and insulin on the decreased beta-adrenergic responsiveness of the gastrointestinal tract in rats with non-insulin-dependent diabetes. ( Altan, VM; Oztürk, Y; Ozüari, A; Yildizoğlu-Ari, N, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, A | 1 |
| Higashi, K | 1 |
| Wakao, S | 1 |
| Sakamoto, K | 1 |
| Ishii, K | 1 |
| Nakahara, T | 1 |
| Şakul, A | 1 |
| Arı, N | 1 |
| Sotnikova, R | 1 |
| Ozansoy, G | 1 |
| Karasu, Ç | 2 |
| Elayan, H | 1 |
| Milic, M | 1 |
| Sun, P | 1 |
| Gharaibeh, M | 1 |
| Ziegler, MG | 1 |
| Oztürk, Y | 5 |
| Yildizoğlu-Ari, N | 3 |
| Ozüari, A | 1 |
| Altan, VM | 5 |
| Ozçelikay, AT | 1 |
| Beenen, OH | 1 |
| Batink, HD | 1 |
| Pfaffendorf, M | 1 |
| van Zwieten, PA | 1 |
| Cotter, MA | 1 |
| Cameron, NE | 1 |
| Potter, DE | 2 |
| Wilson, LM | 1 |
| Ellis, S | 2 |
| Bitar, MS | 1 |
| Keis, AF | 1 |
| Owusu, SE | 1 |
| Mulven, R | 1 |
| DeSouza, EB | 1 |
| Altan, N | 1 |
| Yildizoğlu, N | 1 |
| Yidizoğlu-Ari, N | 1 |
| Altinkurt, O | 1 |
| Pekiner, C | 1 |
| Moratinos, J | 1 |
13 other studies available for albuterol and Alloxan Diabetes
| Article | Year |
|---|---|
Probucol prevents the attenuation of β
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Anticholesteremic Agents; Arterioles; Blood | 2017 |
A pyridoindole antioxidant SMe1EC2 regulates contractility, relaxation ability, cation channel activity, and protein-carbonyl modifications in the aorta of young and old rats with or without diabetes mellitus.
Topics: Acetylcholine; Aging; Albuterol; Animals; Antioxidants; Aorta, Thoracic; Diabetes Mellitus, Experime | 2018 |
Chronic β2 adrenergic agonist, but not exercise, improves glucose handling in older type 2 diabetic mice.
Topics: Adrenergic Agonists; Aging; Albuterol; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diab | 2012 |
The effects of glyburide and insulin on the decreased beta-adrenergic responsiveness of the gastrointestinal tract in rats with non-insulin-dependent diabetes.
Topics: Albuterol; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diges | 1994 |
Effect of insulin on the decreased beta-adrenergic responses of duodenum and atrium isolated from streptozotocin diabetic rats.
Topics: Albuterol; Animals; Body Weight; Diabetes Mellitus, Experimental; Duodenum; Heart; Heart Atria; In V | 1993 |
Beta-andrenoceptors in the hearts of diabetic-hypertensive rats: radioligand binding and functional experiments.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Blood Glucose; Blood Pressure; Body Weight; Cardiotoni | 1997 |
Correction of neurovascular deficits in diabetic rats by beta2-adrenoceptor agonist and alpha1-adrenoceptor antagonist treatment: interactions with the nitric oxide system.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-2 Receptor Ag | 1998 |
Changes in plasma glucose and insulin levels induced by adrenergic agents in normal and alloxan-diabetic rats.
Topics: Albuterol; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drug Interactions; Epinephrine; | 1977 |
Impairment of albuterol-induced suppression of food intake in diabetes mellitus.
Topics: Albuterol; Animals; Anorexia; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Eat | 1992 |
Effect of lithium on gastro-intestinal complications in alloxan-diabetic rats.
Topics: Albuterol; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Duodenum; Gastrointestinal Disea | 1992 |
Decreased gastro-intestinal responses to certain agonists in streptozotocin- and alloxan-diabetic rats in vitro.
Topics: Albuterol; Animals; Chlorides; Diabetes Mellitus, Experimental; Digestive System; Duodenum; Gastroin | 1987 |
Decreased gastro-intestinal responses to salbutamol and serotonin in streptozotocin-induced diabetes: improving effect of insulin in vivo and in vitro.
Topics: Albuterol; Animals; Diabetes Mellitus, Experimental; Duodenum; In Vitro Techniques; Insulin; Rats; S | 1988 |
Comparative hyperglycemic responses to norepinephrine salbutamol and glucagon in normal and alloxan-diabetic insulin-controlled rabbits.
Topics: Albuterol; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Insulin; Male; Norepin | 1974 |